Table 2.
Parameters of Vascular Endothelial Function Testing at baseline and 16-weeks following supplementation
| Variable | Placebo | 2000 IU | ||||
|---|---|---|---|---|---|---|
| Baseline | 16 weeks | p-value | Baseline | 16 weeks | p-value | |
| Baseline diameter (cm) | 0.351±0.015 | 0.350±0.016 | 0.85 | 0.332±0.056 | 0.332±0.011 | 0.82 |
| Peak diameter (cm) | 0.374±0.015 | 0.369±0.016 | 0.44 | 0.356±0.01 | 0.362±0.013 | 0.39 |
| Absolute change (cm) | 0.023±0.003 | 0.018±0.002 | 0.15 | 0.025±0.003 | 0.029±0.003* | 0.17 |
| Time to peak vasodilation (s) | 38±3 | 43±4 | 0.24 | 54±6† | 43±3 | 0.02 |
Note: P-values denote within group effects.
Significant (p=0.01) from Placebo 16 weeks
Significant (p=0.02) from Placebo Baseline